Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) discuss the most anticipated hot line studies to be unveiled at ESC Congress 2025. Tune in for their in-depth analysis to get ahead of the curve.

ESC Congress 2025 Hot Line Trials Discussed:

VICTOR

VICTORIA

DIGIT-HF

DAPA-ACT-HF-TIMI

REBOOT-CNIC

BETAMI-DANBLOCK

REFINE ICD

Stay tuned for Radcliffe Cardiology’s in-depth coverage of these and other pivotal trials from ESC Congress 2025.